When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMPE - Ampio Pharma (+25%) on go with study of Ampion in COVID-19
Ampio Pharmaceuticals Inc.
Following FDA sign-off, Ampio Pharmaceuticals (AMPE+24.9%) has initiated a Phase 1 clinical trial evaluating intravenous Ampion therapy on hospitalized COVID-19 patients on supplemental oxygen.
More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,